KRRO is trading 5% up today at $13.64, extending a strong multi-day rally from recent lows despite a lack of fresh company-specific headlines or filings.
- The move appears to be driven by momentum follow-through and investor positioning following prior positive analyst coverage and a March 2026 financing announcement.
- With major indices mixed, the gain reflects stock-specific biotech risk appetite rather than a clearly identified news-driven catalyst.